Nevro (NVRO)
(Delayed Data from NYSE)
$5.85 USD
+0.03 (0.52%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $5.85 0.00 (0.00%) 6:42 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NVRO 5.85 +0.03(0.52%)
Will NVRO be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for NVRO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVRO
Here's Why You Should Retain Nevro (NVRO) Stock for Now
Nevro's (NVRO) Q2 Earnings Beat Estimates, Revenues Down Y/Y
NVRO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Nevro (NVRO) Reports Q2 Loss, Misses Revenue Estimates
LivaNova (LIVN) Beats Q2 Earnings and Revenue Estimates
Here's Why You Should Retain Nevro (NVRO) Stock for Now
Other News for NVRO
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
EnviroGold Global Welcomes New COO for Sustainable Growth
EnviroGold Global Announces Appointment of Chief Operating Officer
Needham medtech & diagnostics analyst holds analyst/industry conference call
Needham medtech & diagnostics analyst holds analyst/industry conference call